1.
Xeloda hand foot syndrome File Format: PDF/Adobe Acrobat Copyright © 2006 by Roche Laboratories Inc. This document was downloaded from www.xeloda.com. All rights reserved. Page 2. Page 3. Page 4. Page 5.
2.
XELODA® (capecitabine)—The First FDA-Approved Oral Chemotherapy In XELODA combination therapy (XELODA plus docetaxel) for breast cancer, the most common adverse events (>10%) in patients receiving either XELODA plus ...
3.
XELODA® (capecitabine)—The First FDA-Approved Oral Chemotherapy XELODA can induce diarrhea, sometimes severe. Patients with severe diarrhea should be carefully monitored and given fluid and electrolyte replacement if ...
4.
XELODA® (capecitabine)—The First FDA-Approved Oral Chemotherapy Learn about XELODA, the first FDA-approved oral chemotherapy for both metastatic breast and colorectal cancer, and Dukes’ C Stage III colon cancer.
5.
What to Expect with XELODA® (capecitabine) Oral Chemotherapy Learn about the possible side effects of XELODA oral chemotherapy in the treatment of ... dry, itchy or discolored skin, rash, nail problems, and hair loss ...
6.
Side Effects of XELODA® (capecitabine) Oral Chemotherapy Learn about the possible side effects of XELODA oral chemotherapy. ... dry, itchy or discolored skin, rash, nail problems, and hair loss; Tiredness, ...
7.
XELODA® (capecitabine)—The First FDA-Approved Oral Chemotherapy Learn about XELODA, the first FDA-approved oral chemotherapy for both metastatic breast and colorectal cancer, and Dukes’ C Stage III colon cancer.
8.
Currently Taking XELODA® (capecitabine) Oral Chemotherapy There are 2 types of XELODA tablets—150mg and 500mg tablets. Your doctor may ask you to take various combinations of both 150 mg and 500 mg tablets together ...
9.
XELODA® (capecitabine)—The First FDA-Approved Oral Chemotherapy The addition of leucovorin to XELODA is not recommended. There was no apparent advantage in response rate by adding leucovorin to XELODA; however, toxicity ...
10.
XELODA® (capecitabine) For Healthcare Professionals The addition of leucovorin to XELODA is not recommended. There was no apparent advantage in response rate by adding leucovorin to XELODA; however, toxicity ...
|